RxDoctor Payments Data

Vanessa Price, APRN

Family · Beaver Dam, KYNPI 1093910119

Payments from drug & device makers

$405in general payments, 2019–2025

Across 24 payments — averaging $16.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$131
  • Otsuka America Pharmaceutical, Inc.$58
  • Boehringer Ingelheim$53
  • Pfizer$52
  • Amgen$45
  • Novo Nordisk$38
  • plus $28 from 2 others

What the payments were for

  • Food & beverage$405100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$405 in reported general payments places this provider in the 45th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$9,182
Medicare patients
58
Services billed
152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate43$48,953
FarxigaDapagliflozin Propanediol31$30,702
OzempicSemaglutide17$23,354
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$18,145
JardianceEmpagliflozin18$13,939
MyrbetriqMirabegron24$13,917
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$11,980
EliquisApixaban12$11,659
Combivent RespimatIpratropium/Albuterol Sulfate11$5,295
Advair HfaFluticasone Propion/Salmeterol12$5,072
Metformin Er GastricMetformin Hcl11$3,478
Albuterol Sulfate HfaAlbuterol Sulfate62$2,338
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$1,666
Levothyroxine Sodium161$1,251
Atorvastatin Calcium178$1,078

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$38$23,35417 claims
Boehringer IngelheimJardiance, Combivent Respimat$53$19,23429 claims
PfizerEliquis$52$11,65912 claims
AbbVieArmour Thyroid$13$47414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 4,374 family providers in Kentucky.

Other family in Beaver Dam

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →